American Association for the Advancement of Science, Science Translational Medicine, 614(13), 2021
DOI: 10.1126/scitranslmed.abc0497
Full text: Unavailable
Childhood posterior fossa group A ependymomas demonstrate integrated metabolic and epigenetic pathways that can be disrupted by metformin.